Nardone Olga Maria, Maeda Yasuharu, Iacucci Marietta
Division of Gastroenterology, Department of Public Health, University Federico II of Naples, Naples, Italy.
APC Microbiome Ireland, College of Medicine and Health, University College Cork, Cork, Ireland.
Therap Adv Gastroenterol. 2024 Oct 18;17:17562848241275294. doi: 10.1177/17562848241275294. eCollection 2024.
The gap between endoscopy and histology is getting closer with the introduction of sophisticated endoscopic technologies. Furthermore, unprecedented advances in artificial intelligence (AI) have enabled objective assessment of endoscopy and digital pathology, providing accurate, consistent, and reproducible evaluations of endoscopic appearance and histologic activity. These advancements result in improved disease management by predicting treatment response and long-term outcomes. AI will also support endoscopy in raising the standard of clinical trial study design by facilitating patient recruitment and improving the validity of endoscopic readings and endoscopy quality, thus overcoming the subjective variability in scoring. Accordingly, AI will be an ideal adjunct tool for enhancing, complementing, and improving our understanding of ulcerative colitis course. This review explores promising AI applications enabled by endoscopy and histology techniques. We further discuss future directions, envisioning a bright future where AI technology extends the frontiers beyond human limits and boundaries.
随着先进内镜技术的引入，内镜检查与组织学之间的差距正在缩小。此外，人工智能（AI）取得了前所未有的进展，能够对内镜检查和数字病理学进行客观评估，对内窥镜外观和组织学活性提供准确、一致且可重复的评估。这些进展通过预测治疗反应和长期结果，改善了疾病管理。人工智能还将通过促进患者招募以及提高内镜读数的有效性和内镜检查质量，支持内镜检查提高临床试验研究设计的标准，从而克服评分中的主观变异性。因此，人工智能将成为增强、补充和改善我们对溃疡性结肠炎病程理解的理想辅助工具。本综述探讨了由内镜检查和组织学技术实现的有前景的人工智能应用。我们进一步讨论了未来方向，展望了人工智能技术拓展超越人类极限和边界的光明未来。
